This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bantar, C E Articles by Bianchini, H M Search for Related Content PubMed PubMed Citation Articles by Bantar, C E Articles by Bianchini, H M

 Previous Article  |  Next Article 

J Clin Microbiol. 1993 July; 31(7): 1921-1923

Synergy characterization for Enterococcus faecalis strains displaying moderately high-level gentamicin and streptomycin resistance.

Laboratorio de Bacteriología Clínica, Centro de Educación Médica e Investigaciones Clínicas, Buenos Aires, Argentina.

ABSTRACT

Synergy of 14 Enterococcus faecalis strains displaying moderately high-level aminoglycoside resistance (MICs, 500 and 256 to 1,000 micrograms/ml for gentamicin and streptomycin, respectively) was characterized by time-kill studies. All strains proved resistant to penicillin plus the respective aminoglycoside. Strains with moderately high-level aminoglycoside resistance should be considered to exhibit high-level resistance in severe infections.

This article has been cited by other articles:

• Bantar, C., Nicola, F., Arenoso, H. J., Galas, M., Soria, L., Dana, D., Rossi, A., Bianchini, H., Jasovich, A. (1999). Pharmacokinetics and Pharmacodynamics of Amoxicillin-Sulbactam, a Novel Aminopenicillin-beta -Lactamase Inhibitor Combination, against Escherichia coli. Antimicrob. Agents Chemother. 43: 1503-1504 [Abstract] [Full Text]